Skip to main content
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IONS ISIN · US4622221004 LEI · 549300SI4ZGLG0BLUZ92 US Manufacturing
Filings indexed 1,795 across all filing types
Latest filing 2026-04-30 Major Shareholding Noti…
Country US United States of America
Listing US IONS

About IONIS PHARMACEUTICALS INC

https://www.ionis.com/

Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers and develops RNA- and DNA-targeted therapeutics. Leveraging its expertise in antisense technology and a deep understanding of genetics, the company creates novel medicines designed to treat a wide range of serious diseases. Its development pipeline and marketed products primarily address neurologic and cardiometabolic disorders, as well as other areas with high unmet patient needs, including rare diseases. The company's approach aims to provide new solutions for complex and often intractable conditions by targeting the root cause of disease at the genetic level.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-30 English
10-Q - IONIS PHARMACEUTICALS INC (0000874015) (Filer)
Interim / Quarterly Report
2026-04-29 English
8-K - IONIS PHARMACEUTICALS INC (0000874015) (Filer)
Regulatory Filings
2026-04-29 English
ARS
Annual Report
2026-04-23 English
DEFA14A
Proxy Solicitation & Information Statement
2026-04-23 English
DEF 14A - IONIS PHARMACEUTICALS INC (0000874015) (Filer)
Proxy Solicitation & Information Statement
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.